179 related articles for article (PubMed ID: 8566958)
1. A missense mutation in the NF2 gene results in moderate and mild clinical phenotypes of neurofibromatosis type 2.
Kluwe L; Mautner VF
Hum Genet; 1996 Feb; 97(2):224-7. PubMed ID: 8566958
[TBL] [Abstract][Full Text] [Related]
2. Clinical manifestations of mutations in the neurofibromatosis type 2 gene in vestibular schwannomas (acoustic neuromas).
Welling DB
Laryngoscope; 1998 Feb; 108(2):178-89. PubMed ID: 9473065
[TBL] [Abstract][Full Text] [Related]
3. Mutations of the neurofibromatosis type 2 gene and lack of the gene product in vestibular schwannomas.
Sainz J; Huynh DP; Figueroa K; Ragge NK; Baser ME; Pulst SM
Hum Mol Genet; 1994 Jun; 3(6):885-91. PubMed ID: 7951231
[TBL] [Abstract][Full Text] [Related]
4. A 163-bp deletion in the neurofibromatosis 2 (NF2) gene associated with variant phenotypes [corrected].
Kluwe L; Pulst SM; Köppen J; Mautner VF
Hum Genet; 1995 Apr; 95(4):443-6. PubMed ID: 7705843
[TBL] [Abstract][Full Text] [Related]
5. Neurofibromatosis 2 phenotypes and germ-line NF2 mutations determined by an RNA mismatch method and loss of heterozygosity analysis in NF2 schwannomas.
Hung G; Faudoa R; Baser ME; Xue Z; Kluwe L; Slattery W; Brackman D; Lim D
Cancer Genet Cytogenet; 2000 Apr; 118(2):167-8. PubMed ID: 10748301
[TBL] [Abstract][Full Text] [Related]
6. CNS Young Investigator Award Lecture: molecular analysis of the neurofibromatosis 2 tumor suppressor.
MacCollin M
Brain Dev; 1995; 17(4):231-8. PubMed ID: 7503383
[TBL] [Abstract][Full Text] [Related]
7. A mutation in the neurofibromatosis type 2 tumor-suppressor gene, giving rise to widely different clinical phenotypes in two unrelated individuals.
Bourn D; Carter SA; Evans DG; Goodship J; Coakham H; Strachan T
Am J Hum Genet; 1994 Jul; 55(1):69-73. PubMed ID: 8023853
[TBL] [Abstract][Full Text] [Related]
8. A point mutation associated with a severe phenotype of neurofibromatosis 2.
MacCollin M; Braverman N; Viskochil D; Ruttledge M; Davis K; Ojemann R; Gusella J; Parry DM
Ann Neurol; 1996 Sep; 40(3):440-5. PubMed ID: 8797533
[TBL] [Abstract][Full Text] [Related]
9. Identification of NF2 germ-line mutations and comparison with neurofibromatosis 2 phenotypes.
Kluwe L; Bayer S; Baser ME; Hazim W; Haase W; Fünsterer C; Mautner VF
Hum Genet; 1996 Nov; 98(5):534-8. PubMed ID: 8882871
[TBL] [Abstract][Full Text] [Related]
10. Frequent NF2 gene transcript mutations in sporadic meningiomas and vestibular schwannomas.
Lekanne Deprez RH; Bianchi AB; Groen NA; Seizinger BR; Hagemeijer A; van Drunen E; Bootsma D; Koper JW; Avezaat CJ; Kley N
Am J Hum Genet; 1994 Jun; 54(6):1022-9. PubMed ID: 7911002
[TBL] [Abstract][Full Text] [Related]
11. Phenotypic variability associated with 14 splice-site mutations in the NF2 gene.
Kluwe L; MacCollin M; Tatagiba M; Thomas S; Hazim W; Haase W; Mautner VF
Am J Med Genet; 1998 May; 77(3):228-33. PubMed ID: 9605590
[TBL] [Abstract][Full Text] [Related]
12. Neurofibromatosis type 2 attributable to gonosomal mosaicism in a clinically normal mother, and identification of seven novel mutations in the NF2 gene.
Sestini R; Vivarelli R; Balestri P; Ammannati F; Montali E; Papi L
Hum Genet; 2000 Oct; 107(4):366-71. PubMed ID: 11129337
[TBL] [Abstract][Full Text] [Related]
13. Mosaicism in sporadic neurofibromatosis 2 patients.
Kluwe L; Mautner VF
Hum Mol Genet; 1998 Dec; 7(13):2051-5. PubMed ID: 9817921
[TBL] [Abstract][Full Text] [Related]
14. The neurofibromatosis type 2 gene is inactivated in schwannomas.
Twist EC; Ruttledge MH; Rousseau M; Sanson M; Papi L; Merel P; Delattre O; Thomas G; Rouleau GA
Hum Mol Genet; 1994 Jan; 3(1):147-51. PubMed ID: 8162016
[TBL] [Abstract][Full Text] [Related]
15. Screening for germ-line mutations in the NF2 gene.
Mérel P; Hoang-Xuan K; Sanson M; Bijlsma E; Rouleau G; Laurent-Puig P; Pulst S; Baser M; Lenoir G; Sterkers JM
Genes Chromosomes Cancer; 1995 Feb; 12(2):117-27. PubMed ID: 7535084
[TBL] [Abstract][Full Text] [Related]
16. Analysis of mutations in the SCH gene in schwannomas.
Bijlsma EK; Merel P; Bosch DA; Westerveld A; Delattre O; Thomas G; Hulsebos TJ
Genes Chromosomes Cancer; 1994 Sep; 11(1):7-14. PubMed ID: 7529050
[TBL] [Abstract][Full Text] [Related]
17. Combined molecular genetic studies of chromosome 22q and the neurofibromatosis type 2 gene in central nervous system tumors.
Ng HK; Lau KM; Tse JY; Lo KW; Wong JH; Poon WS; Huang DP
Neurosurgery; 1995 Oct; 37(4):764-73. PubMed ID: 8559307
[TBL] [Abstract][Full Text] [Related]
18. Mild familial neurofibromatosis 2 associates with expression of merlin with altered COOH-terminus.
Sainio M; Jääskeläinen J; Pihlaja H; Carpén O
Neurology; 2000 Mar; 54(5):1132-8. PubMed ID: 10720287
[TBL] [Abstract][Full Text] [Related]
19. DNA diagnosis of neurofibromatosis 2. Altered coding sequence of the merlin tumor suppressor in an extended pedigree.
MacCollin M; Mohney T; Trofatter J; Wertelecki W; Ramesh V; Gusella J
JAMA; 1993 Nov; 270(19):2316-20. PubMed ID: 8230593
[TBL] [Abstract][Full Text] [Related]
20. [Type 2 neurofibromatosis without acoustic neuroma].
Mautner VF; Lindenau M; Köppen J; Hazim W; Kluwe L
Zentralbl Neurochir; 1995; 56(2):83-7. PubMed ID: 7639047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
